CYTR Related Company Press Releases
-
CytRx Announces the Presentation of Favorable Results from Novel Combination of Aldoxorubicin and Doxorubicin in a Phase 1b Clinical Trial at ASCO Conference
-
CytRx to Present at the Marcum MicroCap Conference
-
CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors
-
CytRx Issues Letter to Stockholders Providing Business Update
-
CytRx Reports 2013 First Quarter Financial Results
-
CytRx Provides Update on Clinical Programs
-
CytRx Receives Recommendation from Data Safety Monitoring Committee to Complete International Phase 2b Trial with Aldoxorubicin as First-Line Treatment for Soft Tissue Sarcoma
-
CytRx Announces Agreement with FDA on Special Protocol Assessment for Global Pivotal Phase 3 Clinical Trial with Aldoxorubicin for Soft Tissue Sarcoma
Back to CYTR Stock Lookup
